{"id":"W4378903121","doi":"10.1182/bloodadvances.2023010281","title":"Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias","year":2023,"lang":"en","type":"article","venue":"Blood Advances","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of British Columbia; Pediatric Oncology Group","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Medicine; Cyclophosphamide; Cumulative incidence; Internal medicine; Tacrolimus; Incidence (geometry); Transplantation; Graft-versus-host disease; Myelodysplastic syndromes; Bone marrow; Gastroenterology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002268248,0.001042382,0.001272797,0.0002913862,0.0004191473,0.001006412,0.0008538353,0.001127938,0.002036838],"category_scores_gemma":[0.001329922,0.0003583391,0.0009718173,0.0005346967,0.0008967919,0.0006631587,0.0004682687,0.002470585,0.0004533785],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000786028,"about_ca_system_score_gemma":0.001750979,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001470615,"about_ca_topic_score_gemma":0.002345123,"domain_scores_codex":[0.9988769,0.0007024274,0.00005998878,0.0001221687,0.0001077236,0.00013074],"domain_scores_gemma":[0.9987067,0.0002724006,0.000282232,0.0001499533,0.00007150433,0.0005171346],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8916998,0.02597676,0.008914893,0.000344215,0.0008512711,0.000227104,0.0001523806,0.001616608,0.008129214,0.0004592009,0.001929642,0.05969894],"study_design_scores_gemma":[0.631717,0.3478483,0.01317172,0.0000577153,0.0005366281,0.0002991821,0.00004294378,0.0009925812,0.002315007,0.0001745832,0.002825053,0.00001929507],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944253,0.001636442,0.0003369857,0.0003129768,0.0001413255,0.001038295,0.0005307261,0.00005389741,0.001524032],"genre_scores_gemma":[0.9908751,0.001441429,0.001141707,0.0006422778,0.0003535342,0.001986576,0.002143159,0.00002512914,0.001391092],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002268248,"threshold_uncertainty_score":0.01199579,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01346082217133303,"score_gpt":0.282818043183776,"score_spread":0.269357221012443,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}